Tuesday, October 4, 2022


Biotechnology News Magazine

Accelus Announces Opening of New Facilities in Colorado and California

New offices provide additional resources for clinical education, surgical training, and robotic research and development

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the opening of its new robotic research and development lab in Louisville, Colorado and clinical education and surgical training lab in Carlsbad, California.

These facilities supplement Accelus’s corporate headquarters and flagship Accelus Clinical Education (ACE) lab in Palm Beach Gardens, Florida.

“Accessibility is a cornerstone of many of Accelus’s core value propositions—accessibility to anatomy without compromise and accessibility for patients to receive care with our products in outpatient as well as inpatient facilities both domestically and internationally,” said Chris Walsh, Accelus CEO and Co-Founder. “Giving our surgeons and their staff accessibility to clinical training without necessitating a transcontinental journey creates similar advantages to working with Accelus.”

The 3,731-square-foot Louisville office opened in late 2021 and houses much of the development team for Accelus’s Remi Robotic Navigation System while offering facilities to train spine surgeons and their clinical staff on how best to incorporate the Remi system into their spine surgery procedures.

The 5,722-square-foot Carlsbad office opened in early 2022 and features the company’s second ACE surgical lab. The team in Carlsbad hosted their first surgical labs in late March 2022.

Accelus is committed to accelerating minimally invasive spine surgery through its enabling technology with broad accessibility to previously underserved markets. Established in 2021 through the combination of Integrity Implants and Fusion Robotics, the company is focused on providing its proprietary Adaptive Geometry™ technology with pragmatic and economical navigation and robotic solutions with broad clinical use in spine surgery.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine